Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000067

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 12:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 19, 2017P1,000$0.0549A20,877,949D
Common StockMay 19, 2017P1,000$0.0497A20,878,949D
Common StockMay 19, 2017P1,000$0.05A20,879,949D
Common StockMay 19, 2017P300$0.05A20,880,249D
Common StockMay 19, 2017P1,000$0.05A20,881,249D
Common StockMay 19, 2017P1,000$0.05A20,882,249D
Common StockMay 19, 2017P1,000$0.05A20,883,249D
Common StockMay 19, 2017P1,000$0.05A20,884,249D
Common StockMay 19, 2017P1,000$0.05A20,885,249D
Common StockMay 19, 2017P1,000$0.05A20,886,249D
Common StockMay 19, 2017P1,000$0.0499A20,887,249D
Common StockMay 19, 2017P1,000$0.051A20,888,249D
Common StockMay 19, 2017P1,000$0.051A20,889,249D
Common StockMay 19, 2017P1,000$0.053A20,890,249D
Common StockMay 19, 2017P1,000$0.053A20,891,249D
Common StockMay 19, 2017P1,000$0.0527A20,892,249D
Common StockMay 19, 2017P1,000$0.053A20,893,249D
Common StockMay 19, 2017P1,000$0.0529A20,894,249D
Common StockMay 19, 2017P1,000$0.0529A20,895,249D
Common StockMay 19, 2017P1,000$0.0529A20,896,249D
Common StockMay 19, 2017P1,000$0.0529A20,897,249D
Common StockMay 19, 2017P1,000$0.0529A20,898,249D
Common StockMay 19, 2017P1,000$0.0528A20,899,249D
Common StockMay 19, 2017P1,000$0.0528A20,900,249D
Common StockMay 19, 2017P110$0.0529A20,900,359D
Common StockMay 19, 2017P890$0.0529A20,901,249D
Common StockMay 19, 2017P1,000$0.052A20,902,249D
Common StockMay 19, 2017P1,000$0.052A20,903,249D
Common StockMay 19, 2017P1,000$0.0518A20,904,249D
Common StockMay 19, 2017P1,000$0.052A20,905,249D

Table II — derivative securities

No Table II lines on this filing.